These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 143800)

  • 1. [Bronchospasmolysis in chronic obstructive respiratory tract disease. Clinico-pathological studies using theophylline-ethylenediamine, diprophylline, and hexoprenaline].
    Kaik G; Bonelli J; Magometschnigg D; Pittner H; Radda TM; Rameis H
    Wien Med Wochenschr; 1977 Aug; 127(15):484-90. PubMed ID: 143800
    [No Abstract]   [Full Text] [Related]  

  • 2. [(Whole body plethysmographic studies on the bronchospasmolytic effect of injectabls drugs. Comparison of aminophylline, diprophylline and hexoprenaline)].
    Kaik G
    Int J Clin Pharmacol Biopharm; 1976 Oct; 14(3):177-85. PubMed ID: 137218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of chronic airway obstruction. Subacute study with theopyllin-ethylenediamine (Euphyllin retard) in association with the acute administration of hexoprenaline limited dosage aerosol (Etoscol)].
    Wettengel R; Csöri J; Sturm J; Böhning W
    Med Welt; 1979 Oct; 30(43):1609-11. PubMed ID: 514041
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral aminophylline and dikydroxypropyl theophylline in reversible obstructive airway disease: a single-dose, double-blind, crossover comparison.
    Hudson LD; Tyler ML; Petty TL
    Curr Ther Res Clin Exp; 1973 Jul; 15(7):367-72. PubMed ID: 4198297
    [No Abstract]   [Full Text] [Related]  

  • 5. [Long-term study on a new beta2-sympathicomimetic agent and a combination of an oral theophylline-ethylenediamine with retard effect and hexoprenaline (author's transl)].
    Dorow P
    Arzneimittelforschung; 1979; 29(1):145-7. PubMed ID: 375946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The bronchospasmolytic and protective effects of fenoterol, ipratropium bromide, theophylline ethylenediamine and disodium cromoglicicum in inhalation challenge tests; a comparative study (author's transl)].
    Schultze-Werninghaus G; Gonsior E; Meier-Sydow J
    Prax Klin Pneumol; 1979 Apr; 33 Suppl 1():312-6. PubMed ID: 156916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lung function studies with the bronchodilator terbutaline].
    Kaik G; Bonelli J; Hitzenberger G; Laggner A; Magometschnigg D
    Acta Med Austriaca; 1979; 6(2):1-39. PubMed ID: 517068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pulmonary function tests with the bronchodilator Terbutaline].
    Kaik G; Bonelli J; Hitzenberger G; Laggner A; Magometschnigg D
    Acta Med Austriaca Suppl; 1979; 14():1-39. PubMed ID: 161461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term effect and tolerance of broncholytics].
    Schindl R
    Wien Med Wochenschr; 1978; 128(48):1-10. PubMed ID: 664730
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hexoprenaline sulfate in the treatment of bronchospastic processes].
    Niveiro E; Oehling A
    Allergol Immunopathol (Madr); 1974; 2(6):387-98. PubMed ID: 4464780
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of obstructive airway diseases. A new inhalation principle of drug delivery, synchronous to breathing, improves defined dosage aerosol therapy].
    Schmidt OP
    Fortschr Med; 1980 May; 98(20):769-72. PubMed ID: 7409702
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hexoproline in broncho-obstructive syndromes: a double-blind method for comparison with orciprenaline].
    Mariotta S; Pasqua F; Montanari S; Ferrara G; Gammelli G; Gramiccioni E
    Clin Ter; 1982 Aug; 102(4):361-7. PubMed ID: 7140186
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative examination of theophylline-serum-concentrations and bronchospasmolytic effect of cholintheophyllinate (euspirax) and theophyllin-aethylendiamine (euphyllin retard) in patients with obstructive airway diseases (author's transl)].
    Wettengel R; Oellerich M; Schnitker J
    Prax Klin Pneumol; 1979 Nov; 33(11):1125-31. PubMed ID: 523424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of hexoprenaline on respiratory and heart functions in chronic obstructive lung disease].
    Cholevas M; Economidis D; Lefkos N; Sakamadis G; Concouris L
    Wien Med Wochenschr Suppl; 1978; 50():1-7. PubMed ID: 280024
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison of carbuterol, fenoterol and hexoprenaline in allergic asthma.
    Henze F
    S Afr Med J; 1980 Jun; 57(26):1068. PubMed ID: 6893237
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bronchospasmolytic effect of adrenergic beta receptor agonists in bronchial asthma].
    Makel'skiĭ VV
    Ter Arkh; 1976; 40(2):57-60. PubMed ID: 9700
    [No Abstract]   [Full Text] [Related]  

  • 17. [New developments in the field of bronchospasmolytics].
    Nolte D
    Clin Ter; 1980 Jan; 92(1):3-13. PubMed ID: 7449306
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effect of somatostatin on bronchial obstruction in carcinoid (author's transl)].
    Klapdor R; Lanser K; von Wichert P
    Prax Klin Pneumol; 1982 Apr; 36(4):202-5. PubMed ID: 6124963
    [No Abstract]   [Full Text] [Related]  

  • 19. Uterine and cardiovascular effects of fenoterol and hexoprenaline in prostaglandin F2 alpha-induced labor in humans.
    Lipshitz J; Lipshitz EM
    Obstet Gynecol; 1984 Mar; 63(3):396-400. PubMed ID: 6583599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminophylline injection and theophylline tablets: Acute response in partially reversible chronic airway obstruction.
    Freitag A
    Med J Aust; 1976 Apr; 1(14):478-9. PubMed ID: 933924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.